Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Maged Al‐Ammari"'
Publikováno v:
eJHaem, Vol 5, Iss 5, Pp 1057-1062 (2024)
Abstract Hemophagocytic lymphohistiocytosis (HLH) is an immune response syndrome characterized by excessive inflammation and tissue destruction. A limited number of cases involving HLH patients with concomitant multiple myeloma (MM), leading to signi
Externí odkaz:
https://doaj.org/article/c1c100e2e39241e9936bf0da71dde59f
Autor:
Rabab Taha, Fahmi Al-Dhaheri, Naji Dwid, Murad R Almowarey, Maged Al-Ammari, Haytham Abbas, Abdulrahman Alamoudi, Omar Fathaldin, Tarek Mohamed, Hani Almoallim
Publikováno v:
Journal of Applied Hematology, Vol 8, Iss 4, Pp 145-151 (2017)
Hemophagocytic lymphohistiocytosis (HLH) is a rare, life threatening condition characterized by immune dysregulation and benign proliferation of phagocytic cells, macrophages, and histiocytes. Lymphocytes (CD8 T-cells and natural killer cells) also p
Externí odkaz:
https://doaj.org/article/9cc4c67906504c1eafe5951fb157d071
Autor:
Ibraheem H. Motabi, Shaima M. Al Aoun, Maged Al-Ammari, Belal M. Albtoosh, Shahid Iqbal, Syed Y. Altaf, Imran K. Tailor, Mohammed S. Alnoamani, Mubarak S. AlGhamdi, Syed ZA Zaidi, Nawal F. AlShehry, Mohammed A. Marei, Mansour Alfayez
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:720-723
Autor:
Shaima Al Aoun, Ibraheem Motabi, Maged Al Ammari, Nawal Al lshehry, Mohammed Marei, Bilal Albtoosh, Imran Tailor, Syed Altaf, Sayid Zaidi, Mansour Alfayez
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S212
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S378
Context The utilization of HDMTX is commonly used in solid malignancies such as osteosarcoma and hematological malignancies such as acute lymphoblastic leukemia and non-Hodgkin lymphoma. Urine alkalinization using intravenous sodium bicarbonate and c
Autor:
Mansour Alfayez, Ibraheem H. Motabi, Imran K Tailor, Sayid Zaidi, Mohammed A. Marei, Bilal Albtoosh, Nawal Al lshehry, Shaima Al Aoun, Maged Al Ammari, Syed Y Altaf
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S284
Objective: The primary objective is overall response rate (CR/CRi). Design: This is a single-institution, single-arm, phase II study of pre-treatment with azacytidine followed by FLAG for the treatment of relapsed or refractory AML. Setting: Salvage
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S239
Autor:
Soheir S. Adam, Maged Al-Ammari
An association between multiple myeloma (MM) and solid tumours has been previously described.1 Furthermore, autoimmune disorders can precede plasma cell dyscrasias, and the pathogenesis of MM maybe linked to chronic immune stimulation. 2 We describe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::202e6a524510c54a3ea88a67f912d81b
https://europepmc.org/articles/PMC5174897/
https://europepmc.org/articles/PMC5174897/
Publikováno v:
Case Reports in Infectious Diseases, Vol 2016 (2016)
A 30-year-old male patient with acquired immune deficiency syndrome (AIDS) on highly active antiretroviral therapy (HAART) presented with clinical picture suggestive of pulmonary tuberculosis. He was commenced on antituberculosis therapy (ATT) with s
Autor:
Tarek Mohamed, Abdulrahman Al-Amoudi, Naji Dwid, Fahmi Al-Dhaheri, Rabab Taha, Haytham Abbas, Maged Al-Ammari, Murad R Almowarey, Omar Fathaldin, Hani Almoallim
Publikováno v:
Journal of Applied Hematology, Vol 8, Iss 4, Pp 145-151 (2017)
Hemophagocytic lymphohistiocytosis (HLH) is a rare, life threatening condition characterized by immune dysregulation and benign proliferation of phagocytic cells, macrophages, and histiocytes. Lymphocytes (CD8 T-cells and natural killer cells) also p